Literature DB >> 31116879

A study of 51 subtypes of peripheral blood immune cells in newly diagnosed young type 1 diabetes patients.

A Oras1, A Peet2, T Giese3, V Tillmann2, R Uibo1.   

Abstract

Type 1 diabetes (T1D) results from autoimmune destruction of insulin-producing beta cells in pancreatic islets. Various immune cell populations are involved in disease development and natural course. However, to our knowledge, so far there are no comprehensive comparative investigations of all main immune cell populations and their most important subsets at the onset of disease. Therefore, in the current study, we analyzed 51 peripheral blood immune cell populations in 22 young T1D patients and in 25 age-matched controls using a comprehensive polychromatic flow cytometry panel developed for whole blood by the COST Action no. BM0907 ENTIRE (European Network for Translational Immunology Research and Education: From Immunomonitoring to Personalized Immunotherapy) consortium. We found that in T1D patients, frequencies and absolute counts of natural killer (NK) cells, dendritic cells (DC) and T cells, as well as their respective subsets, were significantly altered compared to controls. Further, we observed that changes in several cell populations (e.g. CD14+ CD16+ non-classical monocytes, plasmablasts) were dependent on the age of the patient. In addition to age-related changes, we also found that alterations in immune cell patterns were associated with parameters such as the presence of ketoacidosis and C-peptide serum levels. Our study provides a foundation for future studies investigating different cell lineages and their role in T1D and illustrates the value of polychromatic flow cytometry for evaluating all main peripheral immune cells and their subsets in whole blood samples.
© 2019 British Society for Immunology.

Entities:  

Keywords:  autoimmunity; cell surface molecules; diabetes; pancreas

Year:  2019        PMID: 31116879      PMCID: PMC6718284          DOI: 10.1111/cei.13332

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  44 in total

1.  Induction of CD16+ CD56bright NK cells with antitumour cytotoxicity not only from CD16- CD56bright NK Cells but also from CD16- CD56dim NK cells.

Authors:  E Takahashi; N Kuranaga; K Satoh; Y Habu; N Shinomiya; T Asano; S Seki; M Hayakawa
Journal:  Scand J Immunol       Date:  2007-02       Impact factor: 3.487

Review 2.  Cytokine-producing B lymphocytes-key regulators of immunity.

Authors:  Frances E Lund
Journal:  Curr Opin Immunol       Date:  2008-04-15       Impact factor: 7.486

Review 3.  The geoepidemiology of type 1 diabetes.

Authors:  Andrea T Borchers; Raivo Uibo; M E Gershwin
Journal:  Autoimmun Rev       Date:  2009-12-05       Impact factor: 9.754

4.  A polymorphism in PTPN2 gene is associated with an earlier onset of type 1 diabetes.

Authors:  Laura Espino-Paisan; Hermenegildo de la Calle; Miguel Fernández-Arquero; Maria Angeles Figueredo; Emilio G de la Concha; Elena Urcelay; Jose Luis Santiago
Journal:  Immunogenetics       Date:  2011-01-19       Impact factor: 2.846

5.  CD56brightCD16+ NK cells: a functional intermediate stage of NK cell differentiation.

Authors:  Vivien Béziat; Darragh Duffy; Stéphanie Nguyen Quoc; Magali Le Garff-Tavernier; Julie Decocq; Béhazine Combadière; Patrice Debré; Vincent Vieillard
Journal:  J Immunol       Date:  2011-05-09       Impact factor: 5.422

6.  Type 1 diabetes patients have significantly lower frequency of plasmacytoid dendritic cells in the peripheral blood.

Authors:  Xueqin Chen; Levi H C Makala; Yulan Jin; Diane Hopkins; Andy Muir; Nikhil Garge; Robert H Podolsky; Jin-Xiong She
Journal:  Clin Immunol       Date:  2008-09-30       Impact factor: 3.969

7.  Diabetic ketoacidosis induces in vivo activation of human T-lymphocytes.

Authors:  Abbas E Kitabchi; Frankie B Stentz; Guillermo E Umpierrez
Journal:  Biochem Biophys Res Commun       Date:  2004-03-05       Impact factor: 3.575

8.  Decreased blood dendritic cell counts in type 1 diabetic children.

Authors:  Slavica Vuckovic; Geoff Withers; Mark Harris; Dalia Khalil; Damien Gardiner; Inge Flesch; Sonia Tepes; Ristan Greer; David Cowley; Andrew Cotterill; Derek N J Hart
Journal:  Clin Immunol       Date:  2007-04-25       Impact factor: 3.969

9.  Natural killer cells from children with type 1 diabetes have defects in NKG2D-dependent function and signaling.

Authors:  Huilian Qin; I-Fang Lee; Constadina Panagiotopoulos; Xiaoxia Wang; Alvina D Chu; Paul J Utz; John J Priatel; Rusung Tan
Journal:  Diabetes       Date:  2011-01-26       Impact factor: 9.461

10.  Age of islet autoantibody appearance and mean levels of insulin, but not GAD or IA-2 autoantibodies, predict age of diagnosis of type 1 diabetes: diabetes autoimmunity study in the young.

Authors:  Andrea K Steck; Kelly Johnson; Katherine J Barriga; Dongmei Miao; Liping Yu; John C Hutton; George S Eisenbarth; Marian J Rewers
Journal:  Diabetes Care       Date:  2011-05-11       Impact factor: 19.112

View more
  19 in total

1.  Transcriptional regulatory networks of circulating immune cells in type 1 diabetes: A community knowledgebase.

Authors:  Scott A Ochsner; Rudolf T Pillich; Deepali Rawool; Jeffrey S Grethe; Neil J McKenna
Journal:  iScience       Date:  2022-06-11

2.  Differences in Maturation Status and Immune Phenotypes of Circulating Helios+ and Helios- Tregs and Their Disrupted Correlations With Monocyte Subsets in Autoantibody-Positive T1D Individuals.

Authors:  Yuyue Zhang; Jie Zhang; Yun Shi; Min Shen; Hui Lv; Shu Chen; Yingjie Feng; Heng Chen; Xinyu Xu; Tao Yang; Kuanfeng Xu
Journal:  Front Immunol       Date:  2021-05-12       Impact factor: 7.561

Review 3.  Islet-Resident Dendritic Cells and Macrophages in Type 1 Diabetes: In Search of Bigfoot's Print.

Authors:  Henner Zirpel; Bart O Roep
Journal:  Front Endocrinol (Lausanne)       Date:  2021-04-12       Impact factor: 5.555

Review 4.  The Remission Phase in Type 1 Diabetes: Role of Hyperglycemia Rectification in Immune Modulation.

Authors:  Rong Tang; Ting Zhong; Chao Wu; Zhiguang Zhou; Xia Li
Journal:  Front Endocrinol (Lausanne)       Date:  2019-12-03       Impact factor: 5.555

5.  NK Cell Subsets Changes in Partial Remission and Early Stages of Pediatric Type 1 Diabetes.

Authors:  Laia Gomez-Muñoz; David Perna-Barrull; Adrian Villalba; Silvia Rodriguez-Fernandez; Rosa-Maria Ampudia; Aina Teniente-Serra; Federico Vazquez; Marta Murillo; Jacobo Perez; Raquel Corripio; Joan Bel; Marta Vives-Pi
Journal:  Front Immunol       Date:  2021-01-25       Impact factor: 7.561

Review 6.  NK Cells in Autoimmune Diseases: Protective or Pathogenic?

Authors:  Meifang Liu; Shujuan Liang; Cai Zhang
Journal:  Front Immunol       Date:  2021-03-12       Impact factor: 7.561

7.  Transcriptional networks in at-risk individuals identify signatures of type 1 diabetes progression.

Authors:  Louis-Pascal Xhonneux; Oliver Knight; Åke Lernmark; Ezio Bonifacio; William A Hagopian; Marian J Rewers; Jin-Xiong She; Jorma Toppari; Hemang Parikh; Kenneth G C Smith; Anette-G Ziegler; Beena Akolkar; Jeffrey P Krischer; Eoin F McKinney
Journal:  Sci Transl Med       Date:  2021-03-31       Impact factor: 19.319

8.  Blood Co-Circulating Extracellular microRNAs and Immune Cell Subsets Associate with Type 1 Diabetes Severity.

Authors:  Silvia Garavelli; Sara Bruzzaniti; Elena Tagliabue; Francesco Prattichizzo; Dario Di Silvestre; Francesco Perna; Lucia La Sala; Antonio Ceriello; Enza Mozzillo; Valentina Fattorusso; Pierluigi Mauri; Annibale A Puca; Adriana Franzese; Giuseppe Matarese; Mario Galgani; Paola de Candia
Journal:  Int J Mol Sci       Date:  2020-01-11       Impact factor: 5.923

9.  Mass Cytometry Studies of Patients With Autoimmune Endocrine Diseases Reveal Distinct Disease-Specific Alterations in Immune Cell Subsets.

Authors:  Louise Magnusson; Hugo Barcenilla; Mikael Pihl; Sophie Bensing; Daniel Espes; Per-Ola Carlsson; Rosaura Casas
Journal:  Front Immunol       Date:  2020-02-21       Impact factor: 7.561

10.  Comprehensive flow cytometric reference intervals of leukocyte subsets from six study centers across Europe.

Authors:  A Oras; B Quirant-Sanchez; D Popadic; S Thunberg; O Winqvist; S Heck; M Cwikowski; D Riemann; B Seliger; E Martinez Caceres; R Uibo; T Giese
Journal:  Clin Exp Immunol       Date:  2020-08-03       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.